Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging
- 29 June 2008
- journal article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 14 (7), 767-772
- https://doi.org/10.1038/nm1786
Abstract
Several human progerias, including Hutchinson-Gilford progeria syndrome (HGPS), are caused by the accumulation at the nuclear envelope of farnesylated forms of truncated prelamin A, a protein that is also altered during normal aging. Previous studies in cells from individuals with HGPS have shown that farnesyltransferase inhibitors (FTIs) improve nuclear abnormalities associated with prelamin A accumulation, suggesting that these compounds could represent a therapeutic approach for this devastating progeroid syndrome. We show herein that both prelamin A and its truncated form progerin/LADelta50 undergo alternative prenylation by geranylgeranyltransferase in the setting of farnesyltransferase inhibition, which could explain the low efficiency of FTIs in ameliorating the phenotypes of progeroid mouse models. We also show that a combination of statins and aminobisphosphonates efficiently inhibits both farnesylation and geranylgeranylation of progerin and prelamin A and markedly improves the aging-like phenotypes of mice deficient in the metalloproteinase Zmpste24, including growth retardation, loss of weight, lipodystrophy, hair loss and bone defects. Likewise, the longevity of these mice is substantially extended. These findings open a new therapeutic approach for human progeroid syndromes associated with nuclear-envelope abnormalities.Keywords
This publication has 29 references indexed in Scilit:
- Prelamin A Farnesylation and Progeroid SyndromesJournal of Biological Chemistry, 2006
- Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questionsCellular and Molecular Life Sciences, 2006
- DNA damage responses in progeroid syndromes arise from defective maturation of prelamin AJournal of Cell Science, 2006
- Molecular bases of progeroid syndromesHuman Molecular Genetics, 2006
- Hutchinson–Gilford progeria syndrome: Review of the phenotypeAmerican Journal of Medical Genetics Part A, 2006
- Lamin A-Dependent Nuclear Defects in Human AgingScience, 2006
- Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activationNature, 2005
- Genomic instability in laminopathy-based premature agingNature Medicine, 2005
- What Can Progeroid Syndromes Tell Us About Human Aging?Science, 2004
- Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase–deficient miceNature Genetics, 2002